Ascendis Health (JSE:ASC) 3-Year ROIIC % : 0.00% (As of Jun. 2023)


JSE:ASC Ascendis Health Ltd JSE:ASC
11 GF Score
Price R0.92
View Full Analysis

What is Ascendis Health 3-Year ROIIC %?

Ascendis Health JSE:ASC 11 3-Year ROIIC % is 0.00 as of Jun. 2023. GuruFocus rates JSE:ASC with a GF Score™ of 11/100.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Ascendis Health's 3-Year ROIIC % for the quarter that ended in Jun. 2023 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Ascendis Health's 3-Year ROIIC % or its related term are showing as below:

JSE:ASC's 3-Year ROIIC % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.145
* Ranked among companies with meaningful 3-Year ROIIC % only.

Ascendis Health  (JSE:ASC) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Ascendis Health 3-Year ROIIC % Related Terms


Ascendis Health 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Ascendis Health's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Health 3-Year ROIIC % Chart

Ascendis Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.23 31.22 19.97 4.12 0.02

Ascendis Health Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.97 0.00 4.12 0.00 0.02

JSE:ASC vs PHBI, GCAN, SGBI: 3-Year ROIIC % Comparison

For the Medical Distribution subindustry, Ascendis Health's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Health 3-Year ROIIC % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ascendis Health's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Ascendis Health's 3-Year ROIIC % falls into.


JSE:ASC
11GF Score
Ascendis Health Ltd JSE:ASC
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Health 3-Year ROIIC % Calculation

Ascendis Health's 3-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -197.496 (Jun. 2023) - -196.634313 (Jun. 2020) )/( 611.761 (Jun. 2023) - 10443.515 (Jun. 2020) )
=-0.86168699999999/-9831.754
=0.01%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of 0.00 mean?
Ascendis Health (JSE:ASC) has a 3-Year ROIIC % of 0.00 as of Jun. 2023. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Ascendis Health and its competitors.
Is Ascendis Health's 3-Year ROIIC % too high?
Ascendis Health's current 3-Year ROIIC % is 0.00. Overall, Ascendis Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Health's 3-Year ROIIC % compare to PHBI and GCAN?
Ascendis Health's 3-Year ROIIC % of 0.00 can be compared against companies in the Medical Distribution industry. The industry median 3-Year ROIIC % is 2.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.15, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Ascendis Health and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascendis Health's current 3-Year ROIIC % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Health stock overvalued right now?
Ascendis Health (JSE:ASC) has a current 3-Year ROIIC % of 0.00. The current 3-Year ROIIC % is 0.00. Ascendis Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Ascendis Health (JSE:ASC), the current 3-Year ROIIC % is 0.00 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Health Business Description

Address 1 Carey Street, Wynberg, Sandton, GT, ZAF, 2090
Ascendis Health Ltd is a health and wellness investment holding Company that holds investments in a number of companies that market and distribute a portfolio of brands, products, and medical devices. The company operates in two segments: i) Consumer Health (wellness, health supplements, speciality ingredients and compounded medicines) and ii) Medical Devices (distributor of medical devices, in vitro diagnostic products and orthopaedic equipment). The company generates the majority of its revenue from the Medical Devices segment.
11GF Score

Get the complete analysis for JSE:ASC

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.92
Price